Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
turmeric extract 200 mg + devil's claw extract 100 mg + Indian frankincense extract 125 mg + white willow extract 120 mg + black pepper extract 1.58 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
valerian 300 mg + hops extract 62.5 mg + passiflora incarnata extract 50 mg + balm leaf extract 195 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
regdanvimab 960 mg/16 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
nivolumab 240 mg/24 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
molnupiravir 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
inert substance diluent, 50 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
magnesium glycinate 416.67 mg (magnesium 50 mg) + magnesium citrate 309.35 mg (magnesium 50 mg) + passiflora incarnata extract 18.75 mg + balm leaf extract 97.5 mg + glycine 25 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
risankizumab 150 mg/mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pegvaliase 2.5 mg/0.5 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
nirmatrelvir 150 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
risankizumab 150 mg/mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
zanubrutinib 80 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
thiotepa 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sacituzumab govitecan 180 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
trastuzumab deruxtecan 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cilgavimab 150 mg/1.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tixagevimab 150 mg/1.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pegvaliase 10 mg/0.5 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pegvaliase 20 mg/mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
bemotrizinol 1.8% + diethylamino hydroxybenzoyl hexyl benzoate 4% + homosalate 8% + octocrylene 8% + titanium dioxide 2.5% lotion |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
Mycobacterium bovis BCG Danish strain 30 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
imatinib 600 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent vaccine 2022 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ceramide NP + ceramide AP + hyaluronic acid + ceramide EOP cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
human menopausal gonadotrophin 625 units/mL injection, 0.96 mL pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
human menopausal gonadotrophin 625 units/mL injection, 1.92 mL pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lorazepam 4 mg/mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent adjuvanted geriatric vaccine 2022 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent cell based vaccine 2022 injection, 0.5 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
influenza quadrivalent geriatric vaccine 2022 injection, 0.7 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
midazolam 2.5 mg/0.25 mL oral liquid, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
midazolam 10 mg/mL oral liquid, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
midazolam 5 mg/0.5 mL oral liquid, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
midazolam 7.5 mg/0.75 mL oral liquid, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
white soft paraffin ointment, 5 g tube |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
liquid paraffin 1 g/g liquid, 5 g tube |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
white soft paraffin ointment, 10 g tube |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
iohexol 755 mg (iodine 350 mg)/mL injection, 500 mL bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
suxamethonium chloride dihydrate 100 mg/2 mL injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation + glycopyrronium 10 microgram/actuation inhalation, actuation |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
somatrogon 60 mg/1.2 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
somatrogon 24 mg/1.2 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lidocaine 2% gel |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate moderate exudate 12 cm x 19 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing contact layer lipidocolloid 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing contact layer lipidocolloid with sucrose octasulfate 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing contact layer lipidocolloid with sucrose octasulfate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate moderate exudate 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate moderate exudate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing lipidocolloid moderate exudate 10 cm x 12 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
bandage compression 25 cm to 32 cm two layer bandage |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
bandage compression 18 cm to 25 cm two layer bandage |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing poly-absorbent fibre lipidocolloid with sucrose octasulfate heavy exudate 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing poly-absorbent fibre lipidocolloid with sucrose octasulfate heavy exudate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate heavy exudate 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate heavy exudate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with sucrose octasulfate heavy exudate 8 cm x 8 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing foam lipidocolloid with silicone heavy exudate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing poly-absorbent fibre lipidocolloid with sucrose octasulfate moderate exudate 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing poly-absorbent fibre lipidocolloid with sucrose octasulfate moderate exudate 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing gelling fibre lipidocolloid 15 cm x 20 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing gelling fibre lipidocolloid 10 cm x 10 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing poly-absorbent fibre lipidocolloid with sucrose octasulfate heavy exudate 8 cm x 8 cm dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
paliperidone 1 g/5 mL modified release injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
paliperidone 700 mg/3.5 mL modified release injection, syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
diroximel fumarate 231 mg enteric capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
inert substance diluent, 3.17 mL syringe |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
selinexor 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glatiramer acetate 40 mg/mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tecovirimat 200 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
suxamethonium chloride dihydrate 100 mg/2 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tepotinib 225 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ketorolac trometamol 30 mg/mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
abiraterone acetate 125 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
osilodrostat 10 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
osilodrostat 5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
osilodrostat 1 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
beclometasone dipropionate 200 microgram/actuation + formoterol fumarate dihydrate 6 microgram/actuation inhalation, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
asciminib 40 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
polatuzumab vedotin 30 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
deflazacort 6 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
thiotepa 400 mg injection, chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sodium chloride 0.9% (9 mg/mL) diluent, 400 mL chamber |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
nusinersen 12 mg/5 mL intrathecal injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
azacitidine 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
azacitidine 300 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delamanid 50 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
potassium bromide 850 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
l-methionine 500 mg capsule |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
flunarizine 5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ferric subsulfate (iron 21%) gel, 15 mL bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
avalglucosidase alfa 100 mg/10 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
monkeypox live replication deficient vaccine injection, 0.5 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
polyvalent Central American and South American snake antivenom injection, 10 mL vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 8.93 mg/mL + cannabidiol 8.93 mg/mL spray, actuation |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 20 mg/mL + cannabidiol less than or equal to 1 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pegcetacoplan 1.08 g/20 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol less than 2.5 mg/mL + cannabidiol 25 mg/mL oral oil |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|